| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.66 | 0.0005 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |